Niagen Bioscience

NAGENasdaq United States Health Care Medicinal Chemicals and Botanical Products

Market cap

$246.873 M

$3.12 +2.63%

Close of 7 Aug 2026

Revenue

$129.4M

#2441 by revenue

Earnings

$17.4M

#1922 by earnings

Shares outstanding

79,126,002

Latest filing cover page

P/E ratio

14.2

Cap ÷ net income

Medicinal Chemicals and Botanical Products — ranked by market cap

All 26 →

#13Usana Health SciencesUSNA$285.6M
#14Orchestra BioMedOBIO$253.9M
#15Niagen BioscienceNAGE$246.9M
#16Aurora CannabisACB$185.3M
#17MediWoundMDWD$184.8M

Where these numbers come from

Share counts and financials for Niagen Bioscience are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.